Skip to content or main menu

Erase MS

Laquinimod

Advances in Oral Drugs for Multiple Sclerosis

August 1, 2011

Today, Teva Pharmaceuticals had mixed reports to share regarding laquinimod, an experimental, oral drug for Multiple Sclerosis.

Click here to read more about the clinical study and other oral treatments for Multiple Sclerosis.

Read More »

Latest News - view all

Study Suggests Pediatric MS Patients Can Benefit Greatly from Physical Activity

Posted: Aug 20, 2015A recently published study in the journal Neurology entitled “lower physical activity is associated with higher disease ...

Find us on Facebook. Follow us on Twitter. YouTube. Pinterest. Subscribe to our RSS feed.

Copyright | Site By Urban Jungle | Powered by Inflight